To include your compound in the COVID-19 Resource Center, submit it here.

Abgenix reports ABX-IL8 psoriasis data

ABGX said that in a 94-patient, double-blind, placebo-controlled Phase IIa study, a 3 mg/kg

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE